Assessment of Survival Model Performance Following Inclusion of Epstein-Barr Virus DNA Status in Conventional TNM Staging Groups in Epstein-Barr Virus–Related Nasopharyngeal Carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.24721
Abstract: Key Points Question Can incorporating Epstein-Barr virus DNA status into analysis of the tumor-node-metastasis framework improve cancer staging quality in nasopharyngeal carcinoma? Findings In this multicenter prognostic study of 2354 patients in China, a recursive… read more here.
Keywords: barr virus; epstein barr; nasopharyngeal carcinoma; virus dna ... See more keywords
Synergistic Association of Hepatitis B Surface Antigen and Plasma Epstein-Barr Virus DNA Load on Distant Metastasis in Patients With Nasopharyngeal Carcinoma
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.53832
Abstract: This cohort study investigates the prognostic value and biological associations of hepatitis B surface antigen and plasma Epstein-Barr virus DNA levels with distant metastasis in patients with nasopharyngeal carcinoma. read more here.
Keywords: surface antigen; epstein barr; plasma epstein; hepatitis surface ... See more keywords
Epstein–Barr Virus‐Encoded MicroRNA‐BART18‐3p Promotes Colorectal Cancer Progression by Targeting De Novo Lipogenesis
Sign Up to like & getrecommendations! Published in 2022 at "Advanced Science"
DOI: 10.1002/advs.202202116
Abstract: The Epstein–Barr virus (EBV) genome encodes a cluster of 22 viral microRNAs, called miR‐BamHI‐A rightward transcripts (miR‐BARTs), which are shown to promote the development of cancer. Here, this study reports that EBV‐miR‐BART18‐3p is highly expressed… read more here.
Keywords: ebv mir; epstein barr; mir bart18; lipogenesis ... See more keywords
Epstein–barr virus and multiple sclerosis risk in the finnish maternity cohort
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Neurology"
DOI: 10.1002/ana.25532
Abstract: To determine whether maternal Epstein–Barr virus (EBV) IgG antibody levels are associated with risk of multiple sclerosis (MS) in the offspring. read more here.
Keywords: barr virus; epstein barr; multiple sclerosis; risk ... See more keywords
Clinical utility of Epstein‐Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Communications"
DOI: 10.1002/cac2.12100
Abstract: Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor ubiquitously associated with the Epstein‐Barr virus (EBV), which is highly prevalent in South China, Southeast Asia, and North Africa. Despite being a highly radio‐sensitive and treatable cancer,… read more here.
Keywords: epstein barr; detection; dna; barr virus ... See more keywords
Relationship between pretreatment concentration of plasma Epstein‐Barr virus DNA and tumor burden in nasopharyngeal carcinoma: An updated interpretation
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Medicine"
DOI: 10.1002/cam4.1858
Abstract: Pretreatment plasma Epstein‐Barr virus (EBV) DNA is an important tumor marker and prognostic factor in nasopharyngeal carcinoma (NPC). This study aimed to clarify the relationship between plasma EBV DNA level and tumor burden. read more here.
Keywords: plasma epstein; epstein barr; plasma; dna ... See more keywords
Epstein–Barr virus DNA change level combined with tumor volume reduction ratio after inductive chemotherapy as a better prognostic predictor in locally advanced nasopharyngeal carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4964
Abstract: To explore the prognosis predicting ability of the combined factors, Epstein–Barr virus DNA change level (EBVCL) and tumor volume reduction ratio (TVRR) after inductive chemotherapy (IC), in locally advanced nasopharyngeal carcinoma (LANPC). read more here.
Keywords: virus dna; change level; epstein barr; tumor volume ... See more keywords
Association of tumors having Epstein–Barr virus in surrounding lymphocytes with poor prognosis
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4967
Abstract: Infection with certain viruses is an important cause of cancer. The Pan‐Cancer Analysis of Whole Genomes (PCAWG) Consortium recently analyzed the whole‐genome sequencing (WGS) data from 2656 cases across 21 cancer types, and indicated that… read more here.
Keywords: prognosis; epstein barr; surrounding lymphocytes; ebv positive ... See more keywords
Epstein‐Barr virus‐specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma
Sign Up to like & getrecommendations! Published in 2017 at "Cancer"
DOI: 10.1002/cncr.30541
Abstract: Early‐stage and intermediate‐stage nasopharyngeal cancer (NPC) generally carry a good prognosis, but for patients with recurrent, metastatic disease, options are limited. In the current study, the authors present a phase 1/2 study to evaluate the… read more here.
Keywords: barr virus; recurrent metastatic; epstein barr; immunotherapy ... See more keywords
Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein‐Barr virus in situ assays
Sign Up to like & getrecommendations! Published in 2018 at "Cancer"
DOI: 10.1002/cncr.31131
Abstract: In their recent study, Ali et al reported on the genomic profiles of 190 nasopharyngeal carcinoma (NPC) cases with different subtypes: 20 nasopharyngeal adenocarcinoma cases, 62 nasopharyngeal squamous cell carcinoma (NPSCC) cases, and 108 nasopharyngeal… read more here.
Keywords: epstein barr; carcinoma; genomic profiles; study ... See more keywords
Multicenter study of pediatric Epstein‐Barr virus–negative monomorphic post solid organ transplant lymphoproliferative disorders
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34600
Abstract: Pediatric Epstein‐Barr virus–negative monomorphic post solid organ transplant lymphoproliferative disorder [EBV(−)M‐PTLD] comprises approximately 10% of M‐PTLD. No large multi‐institutional pediatric‐specific reports on treatment and outcome are available. read more here.
Keywords: virus negative; negative monomorphic; epstein barr; pediatric epstein ... See more keywords